» Authors » Linxin Li

Linxin Li

Explore the profile of Linxin Li including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 110
Citations 2153
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li L, Zhang L, Zhao Y, Xie Q, He X, He X, et al.
Annu Int Conf IEEE Eng Med Biol Soc . 2025 Mar; 2024:1-4. PMID: 40039243
Fluorescence Molecular Tomography (FMT) is an optical molecular imaging technique with high sensitivity. Multi-point excitation and multi-view measurement have improved the recovered results while also resulting in high computation and...
2.
Li L, Lioutas V, Akyea R, Gerner S, Lau K, Ramage E, et al.
J Stroke . 2025 Feb; 27(1):41-51. PMID: 39916453
Randomized clinical trials are important in both clinical and academic stroke communities with increasing numbers of new design concepts emerging. One of the "less traditional" designs that have gained increasing...
3.
Aguiar de Sousa D, Zietz A, Zedde M, Katsanos A, Li L, Marti-Fabregas J, et al.
Eur Stroke J . 2025 Feb; :23969873251316430. PMID: 39904756
Promoting the highest quality, evidence-based research across Europe is a priority of the European Stroke Organisation (ESO). The ESO Guideline Board communicate and promote evidence-based recommendations for clinical practice through...
4.
Dias D, Oliveira E, Marti-Diaz R, Andrews S, Chocarro-Calvo A, Bellini A, et al.
bioRxiv . 2025 Jan; PMID: 39764020
Within cells multiple related transcription factors targeting the same sequences may co-exist, leading to potential regulatory cooperativity, redundancy or competition. Yet the differential roles and biological functions of co-targeting transcription...
5.
Guo Q, Li J, Wang J, Li L, Wei J, Zhang L
Front Pharmacol . 2024 Dec; 15:1502298. PMID: 39734406
CAR-T cell therapy, a cutting-edge cellular immunotherapy with demonstrated efficacy in treating hematologic malignancies, also exhibits significant promise for addressing autoimmune diseases. This innovative therapeutic approach holds promise for achieving...
6.
Katsanos A, Lioutas V, Yperzeele L, Ullberg T, Li L, Ramage E, et al.
J Stroke Cerebrovasc Dis . 2024 Nov; 34(1):108132. PMID: 39532192
Introduction: The adoption of non-inferiority trial designs for assessing new interventions in stroke treatment is on the rise. We designed a survey to assess stroke specialists' understanding and familiarity with...
7.
McCabe J, Walsh C, Gorey S, Arnold M, DeMarchis G, Harris K, et al.
Stroke . 2024 Oct; 55(12):2825-2834. PMID: 39479747
Background: Inflammation promotes atherogenesis. Randomized controlled trials of anti-inflammatory therapies for prevention after stroke have not yet demonstrated clear benefit. IL-6 (interleukin-6) and hsCRP (high-sensitivity C-reactive protein) are independently associated...
8.
Tunkl C, Agarwal A, Ramage E, Velez F, Roushdy T, Ullberg T, et al.
Int J Stroke . 2024 Oct; 20(3):297-309. PMID: 39460528
Background: Despite the proven efficacy of telestroke in improving clinical outcomes by providing access to specialized expertise and allowing rapid expert hyperacute stroke management and decision-making, detailed operational evidence is...
9.
Reeves M, Gall S, Li L
Stroke . 2024 Oct; 55(11):2726-2730. PMID: 39435534
Evidence generated from randomized clinical trials (RCTs) plays an indispensable role in advancing clinical stroke care. Although the number of stroke-related RCTs published every year has grown exponentially over the...
10.
Wu Z, Su Y, Li J, Liu X, Liu Y, Zhao L, et al.
Stem Cell Res Ther . 2024 Oct; 15(1):367. PMID: 39415276
Stem cell therapy constitutes a pivotal subject in contemporary discourse, with donor stem cells having been employed in research and clinical treatments for several decades. Primary cell transplantation encompasses diverse...